IE41024B1 - Process for obtaining antigens from schistosomes, agent containing these antigens and its use - Google Patents

Process for obtaining antigens from schistosomes, agent containing these antigens and its use

Info

Publication number
IE41024B1
IE41024B1 IE940/75A IE94075A IE41024B1 IE 41024 B1 IE41024 B1 IE 41024B1 IE 940/75 A IE940/75 A IE 940/75A IE 94075 A IE94075 A IE 94075A IE 41024 B1 IE41024 B1 IE 41024B1
Authority
IE
Ireland
Prior art keywords
antigens
schistosomes
agent containing
obtaining
way
Prior art date
Application number
IE940/75A
Other languages
English (en)
Other versions
IE41024L (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IE41024L publication Critical patent/IE41024L/xx
Publication of IE41024B1 publication Critical patent/IE41024B1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IE940/75A 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use IE41024B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2420706A DE2420706C3 (de) 1974-04-29 1974-04-29 Verfahren zum Herstellen von spezifischen Antigenen aus Schistosomen und jene enthaltendes Mittel

Publications (2)

Publication Number Publication Date
IE41024L IE41024L (en) 1975-10-29
IE41024B1 true IE41024B1 (en) 1979-10-10

Family

ID=5914244

Family Applications (1)

Application Number Title Priority Date Filing Date
IE940/75A IE41024B1 (en) 1974-04-29 1975-04-28 Process for obtaining antigens from schistosomes, agent containing these antigens and its use

Country Status (16)

Country Link
JP (1) JPS50145518A (enExample)
AT (1) AT344329B (enExample)
BE (1) BE828565A (enExample)
CA (1) CA1052694A (enExample)
CH (1) CH617775A5 (enExample)
DE (1) DE2420706C3 (enExample)
DK (1) DK140044C (enExample)
EG (1) EG12734A (enExample)
ES (1) ES436866A1 (enExample)
FR (1) FR2268532B1 (enExample)
GB (1) GB1478082A (enExample)
IE (1) IE41024B1 (enExample)
IT (1) IT1049537B (enExample)
LU (1) LU72375A1 (enExample)
NL (1) NL7504853A (enExample)
ZA (1) ZA752717B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2356428A1 (fr) * 1976-06-29 1978-01-27 Inserm Ctre Technologie Biomed Procede de preparation d'un agent immunologique antiparasitaire, produit obtenu et son application
FR2601037B1 (fr) * 1986-07-03 1988-10-21 Pasteur Institut Peptide presentant des proprietes antigeniques isole de la proteine 28 kd de s. mansoni et son procede d'isolement, anticorps monoclonaux reconnaissant au moins un epitope dudit peptide et application de celui-ci dans l'induction de la synthese d'anticorps neutralisants
KR20230092004A (ko) * 2020-10-27 2023-06-23 메르크 파텐트 게엠베하 쉬스토소마 감염의 검출을 위한 단백질

Also Published As

Publication number Publication date
DK184575A (da) 1975-10-30
FR2268532B1 (enExample) 1980-01-25
DE2420706C3 (de) 1979-11-22
ZA752717B (en) 1976-03-31
DE2420706A1 (de) 1975-10-30
FR2268532A1 (enExample) 1975-11-21
DK140044B (da) 1979-06-11
ATA325475A (de) 1977-11-15
CA1052694A (en) 1979-04-17
JPS50145518A (enExample) 1975-11-21
NL7504853A (nl) 1975-10-31
IT1049537B (it) 1981-02-10
LU72375A1 (enExample) 1977-02-03
DK140044C (da) 1979-11-12
IE41024L (en) 1975-10-29
DE2420706B2 (de) 1979-03-22
AT344329B (de) 1978-07-10
BE828565A (fr) 1975-10-29
CH617775A5 (en) 1980-06-13
GB1478082A (en) 1977-06-29
EG12734A (en) 1979-06-30
ES436866A1 (es) 1977-01-01

Similar Documents

Publication Publication Date Title
FI93310C (fi) Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan
AT327390B (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
ES398962A1 (es) Un procedimiento para la preparacion de una composicion de enzima.
HK59984A (en) A process for the preparation of a sterile injectable physiologically acceptable solution of an x-ray contrast agent and solutions of the x-ray contrast agent and a buffer
ATE20309T1 (de) Pharmazeutische zubereitung.
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
GB1522006A (en) Feline calicivirus vaccine and a process for the production thereof
MX157054A (es) Procedimiento para preparar derivados de disenzoxazepina
IE41024B1 (en) Process for obtaining antigens from schistosomes, agent containing these antigens and its use
IT1064505B (it) Sacchetto universale di plastica di separazione del sangue per la preparazione sterile di siero sanguigno per l'uso singolo
CH557382A (fr) Procede de preparation de l'acide 7-((alpha)-hydroxy-(alpha)-phenyl)-acetamido-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylique et de ses derives.
Klein The mechanism of the virucidal action of ascorbic acid
NL7903352A (nl) Werkwijze ter bereiding van cyclohexaancarbonzuur- derivaten, alsmede werkwijze ter bereiding van farma- ceutische preparaten ermede.
SE7706425L (sv) Forfarande for framstellning av polyribonukleotider med aktivitet vid alstrandet av leukocyter och blodplettar
Seidel The life cycle in vitro of Hymenolepis microstoma (Cestoda)
FI99114B (fi) Menetelmä tyvikalvoproteiinien eristämiseksi ihmis- ja eläinkudoksista
SU813844A1 (ru) Состав дл низкотемпературного консервировани лейкоцитов
ES387885A1 (es) Metodo de preparacion de sulfato de condroitina.
GB1404225A (en) Extraction of physiologically active substrates from parathyroid
ATE4637T1 (de) Pentadecapeptid, verfahren zu seiner herstellung und immunisierendes mittel.
DK299981A (da) Fremgangsmaade til fremstilling af 1-s-alkyl-2-0-acyl-3-phosphocolin-1-mercapto-2.3-propandioler
Carrel An Address On The Method Of Tissue Culture And Its Bearing On Pathological Problems
GB806950A (en) Production of pharmaceutical preparations
DAVIS et al. Intravenous use of vitamin K1 oxide
AT342761B (de) Verfahren zur herstellung von homopyrimidazol-derivate enthaltenden, stabilen pharmazeutischen praparaten zur oralen verabreichung